What is nOCD?
nOCD operates at the intersection of technology and clinical psychology, providing a dedicated platform for individuals suffering from Obsessive-Compulsive Disorder. The company distinguishes itself by offering live video sessions with licensed therapists who specialize in Exposure and Response Prevention (ERP), widely recognized as the gold standard for OCD treatment. By digitizing access to these specialized interventions, nOCD effectively bridges the gap between patients and high-quality, evidence-based care, addressing a critical need in the behavioral health market. Their model is designed to empower patients through personalized coaching and expert-led programs, positioning the firm as a transformative force in the digital health landscape.
How much funding has nOCD raised?
nOCD has raised a total of $80.2M across 5 funding rounds:
Private Equity
$1M
Debt
$150K
Series A
$12M
Series B
$33M
Other Financing Round
$34M
Private Equity (2017): $1M with participation from 7 Wire Ventures
Debt (2020): $150K led by PPP
Series A (2020): $12M supported by 7Wire Ventures, Hyde Park Angels, Chicago Ventures, and Meridian Street Capital
Series B (2021): $33M featuring F-Prime Capital Partners, Eight Roads, Chicago Ventures, Kaiser Permanente Ventures, 7wireVentures, and Health Enterprise Partners
Other Financing Round (2023): $34M backed by Longitude Capital, Cigna Ventures, Eight Roads Capital, Kaiser Permanente Ventures, 7wireVentures, and Health Enterprise Partners
Key Investors in nOCD
7wireVentures
7wire Ventures is a firm that builds and invests in early-stage digital health companies focused on creating informed and connected health consumers.
Health Enterprise Partners
HEP Fund partners with organizations transforming the healthcare industry to enhance healthcare delivery through deep industry knowledge and strategic advice.
Longitude Capital
Longitude Capital is a healthcare-focused venture capital firm that invests in biotechnology, medical technology, and health solutions companies.
What's next for nOCD?
With the infusion of recent capital, nOCD is well-positioned to accelerate its growth strategy, focusing on expanding its clinical network and enhancing its technological infrastructure. The company's roadmap likely involves deepening its integration with existing healthcare delivery systems and scaling its reach to serve a broader patient demographic. As the digital health sector continues to mature, nOCD's focus on specialized, high-efficacy treatment models provides a robust foundation for long-term sustainability and continued market penetration. Future initiatives will likely prioritize the refinement of its AI-driven coaching tools and the expansion of strategic partnerships with major payers and providers to ensure broader access to its proprietary ERP-based care.
See full nOCD company page
